What we do
News
Insights
Our work
LucidSearch
QuickAnswers

Contact Us

Search

Amgen

Obesity Weekly News

Obesity Weekly News - May 6th 2025

Obesity Latest News: GLP-1 Pill Update, Discount Wars & Pharma Shakeups In…

Obesity Weekly News

Obesity Weekly News - Feb 12th 2025

Latest obesity treatment advancements: Clinical trial updates and…

Biopharma CVC portfolios 2023

Do you want to gain insights into the CVC portfolios of 19 Biopharma Companies and Google? Then read below!

Over the past few years, corporate venture capital (CVC) companies backed by or…

Oncolytic Virus Treatments

Oncolytic viruses: From promise to reality

The countless cytotoxic effects of traditional chemotherapy have created the…

by Soumya Shastry

Categories

Insights
Case studies
News

Recent Posts

Public Health Weekly News – June 13th 2025
Respiratory Weekly News – June 13th 2025
Vaccines Weekly Update – June 13th 2025
Cell and Gene Therapy Weekly News – June 12th 2025
Rare Diseases Weekly News – June 12th 2025

Tags

advanced therapies antimicrobial resistance bioinformatics biosimilar drugs cancer co-pilot complex innovative design corporate venture capital dostarlimab Elranatamab ESMO 2021 Galderma GDM gene editing gene therapy approval Glioblastoma GLP1 updates Healthcare Innovation hematology hpv HPV Vaccine kidney disease lung cancer MigraineTreatment MPS IIIB mRNA technology MSA NFTs in healthcare non viral vectors Norovirus Omada health pediatric health pharma Progressive Supranuclear Palsy pulmonary care rare disease RSV Prevention SCLC Sema4 Smart Health SpringWorks stroke recovery T2D vaccine distribution οur work

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Public Health Weekly News – June 13th 2025
Respiratory Weekly News – June 13th 2025
Vaccines Weekly Update – June 13th 2025
Cell and Gene Therapy Weekly News – June 12th 2025
Rare Diseases Weekly News – June 12th 2025

TAGS

advanced therapies antimicrobial resistance bioinformatics biosimilar drugs cancer co-pilot complex innovative design corporate venture capital dostarlimab Elranatamab ESMO 2021 Galderma GDM gene editing gene therapy approval Glioblastoma GLP1 updates Healthcare Innovation hematology hpv HPV Vaccine kidney disease lung cancer MigraineTreatment MPS IIIB mRNA technology MSA NFTs in healthcare non viral vectors Norovirus Omada health pediatric health pharma Progressive Supranuclear Palsy pulmonary care rare disease RSV Prevention SCLC Sema4 Smart Health SpringWorks stroke recovery T2D vaccine distribution οur work

What we do
News
Insights
Our work
LucidSearch
QuickAnswers

© 2025 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy